Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 91 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Multi-Site Benchmark Study for Standardized Relative Cerebral Blood Volume in Untreated Brain Metastases Using the DSC-MRI Consensus Acquisition Protocol.
Loizzo SK, Prah MA, Kong MJ, Phung D, Urcuyo JC, Ye J, Attenello FJ, Mendoza J, Zhou Y, Shiroishi MS, Hu LS, Schmainda KM
AJNR Am J Neuroradiol, ajnr.A8531, 10 Oct 2024
Cited by: 0 articles | PMID: 39389776
Add to export list
Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.
Anil A, Stokes AM, Karis JP, Bell LC, Eschbacher J, Jennings K, Prah MA, Hu LS, Boxerman JL, Schmainda KM, Quarles CC
AJNR Am J Neuroradiol, 45(10):1545-1551, 03 Oct 2024
Cited by: 0 articles | PMID: 38782593
Add to export list
Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.
Gagnon L, Gupta D, Mastorakos G, White N, Goodwill V, McDonald CR, Beaumont T, Conlin C, Seibert TM, Nguyen U, Hattangadi-Gluth J, Kesari S, Schulte JD, Piccioni D, Schmainda KM, Farid N, Dale AM, Rudie JD
Radiol Artif Intell, 6(5):e230489, 01 Sep 2024
Cited by: 0 articles | PMID: 39166970 | PMCID: PMC11427928
Add to export list Free full text in Europe PMC
Practical guidance to identify and troubleshoot suboptimal DSC-MRI results.
Prah MA, Schmainda KM
Front Radiol, 4:1307586, 20 Feb 2024
Cited by: 0 articles | PMID: 38445104
Add to export list
Application of Delta T1 maps for quantitative and objective assessment of extent of resection and survival prediction in glioblastoma.
Laing BR, Prah MA, Best BJ, Krucoff MO, Mueller WM, Schmainda KM
Neurosurg Pract, 5(1):e00077, 17 Jan 2024
Cited by: 0 articles | PMID: 38919518 | PMCID: PMC11198967
Add to export list Free full text in Europe PMC
Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.
Al-Gizawiy MM, Wujek RT, Alhajala HS, Cobb JM, Prah MA, Doan NB, Connelly JM, Chitambar CR, Schmainda KM
Front Oncol, 13:1278157, 15 Jan 2024
Cited by: 1 article | PMID: 38288102 | PMCID: PMC10822938
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Magnetic resonance imaging-derived relative cerebral blood volume characteristics in a case of pathologically confirmed neurocysticercosis: illustrative case.
Botros NE, Polinger-Hyman D, Beck RT, Kleefisch C, Mrachek EKS, Connelly J, Schmainda KM, Krucoff MO
J Neurosurg Case Lessons, 6(25):CASE23446, 18 Dec 2023
Cited by: 0 articles | PMID: 38109728 | PMCID: PMC10732321
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.
Hu LS, D'Angelo F, Weiskittel TM, Caruso FP, Fortin Ensign SP, Blomquist MR, Flick MJ, Wang L, Sereduk CP, Meng-Lin K, De Leon G, Nespodzany A, Urcuyo JC, Gonzales AC, Curtin L, Lewis EM, Singleton KW, Dondlinger T, Anil A, [...] Tran NL
Nat Commun, 14(1):6066, 28 Sep 2023
Cited by: 4 articles | PMID: 37770427 | PMCID: PMC10539500
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength.
Shiroishi MS, Weinert D, Cen SY, Varghese B, Dondlinger T, Prah M, Mendoza J, Nazemi S, Ameli N, Amini N, Shohas S, Chen S, Bigjahan B, Zada G, Chen T, Neman-Ebrahim J, Chang EL, Chow FE, Fan Z, [...] Schmainda KM
Front Oncol, 13:1156843, 20 Sep 2023
Cited by: 1 article | PMID: 37799462 | PMCID: PMC10548232
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Advanced MR Techniques for Preoperative Glioma Characterization: Part 2.
Hangel G, Schmitz-Abecassis B, Sollmann N, Pinto J, Arzanforoosh F, Barkhof F, Booth T, Calvo-Imirizaldu M, Cassia G, Chmelik M, Clement P, Ercan E, Fernández-Seara MA, Furtner J, Fuster-Garcia E, Grech-Sollars M, Guven NT, Hatay GH, Karami G, [...] Emblem KE
J Magn Reson Imaging, 57(6):1676-1695, 13 Mar 2023
Cited by: 8 articles | PMID: 36912262 | PMCID: PMC10947037
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625.
Boxerman JL, Snyder BS, Barboriak DP, Schmainda KM
Front Oncol, 13:1061502, 26 Jan 2023
Cited by: 3 articles | PMID: 36776298 | PMCID: PMC9909012
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma.
Amidon RF, Santos-Pinheiro F, Straza M, Prah MA, Mueller WM, Krucoff MO, Connelly JM, Kleefisch CJ, Coss DJ, Cochran EJ, Bovi JA, Schultz CJ, Schmainda KM
Front Oncol, 12:1066191, 06 Dec 2022
Cited by: 1 article | PMID: 36561526 | PMCID: PMC9763264
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.
Malik DG, Rath TJ, Urcuyo Acevedo JC, Canoll PD, Swanson KR, Boxerman JL, Quarles CC, Schmainda KM, Burns TC, Hu LS
Front Radiol, 2:809373, 15 Apr 2022
Cited by: 5 articles | PMID: 37492687 | PMCID: PMC10365126
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity.
Reith TP, Prah MA, Choi EJ, Lee J, Wujek R, Al-Gizawiy M, Chitambar CR, Connelly JM, Schmainda KM
Tomography, 8(2):789-797, 15 Mar 2022
Cited by: 5 articles | PMID: 35314642 | PMCID: PMC8938779
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.
Henriksen OM, Del Mar Álvarez-Torres M, Figueiredo P, Hangel G, Keil VC, Nechifor RE, Riemer F, Schmainda KM, Warnert EAH, Wiegers EC, Booth TC
Front Oncol, 12:810263, 03 Mar 2022
Cited by: 24 articles | PMID: 35359414 | PMCID: PMC8961422
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.
Booth TC, Wiegers EC, Warnert EAH, Schmainda KM, Riemer F, Nechifor RE, Keil VC, Hangel G, Figueiredo P, Álvarez-Torres MDM, Henriksen OM
Front Oncol, 11:811425, 28 Feb 2022
Cited by: 13 articles | PMID: 35340697 | PMCID: PMC8948428
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Magnetic Resonance Imaging Mapping of Brain Tumor Burden: Clinical Implications for Neurosurgical Management: Case Report.
Connelly JM, Prah MA, Santos-Pinheiro F, Mueller W, Cochran E, Schmainda KM
Neurosurg Open, 2(4):okab029, 16 Sep 2021
Cited by: 5 articles | PMID: 34661110 | PMCID: PMC8508085
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness.
McGarry SD, Brehler M, Bukowy JD, Lowman AK, Bobholz SA, Duenweg SR, Banerjee A, Hurrell SL, Malyarenko D, Chenevert TL, Cao Y, Li Y, You D, Fedorov A, Bell LC, Quarles CC, Prah MA, Schmainda KM, Taouli B, [...] LaViolette PS
J Magn Reson Imaging, 55(6):1745-1758, 12 Nov 2021
Cited by: 7 articles | PMID: 34767682 | PMCID: PMC9095769
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and ¹⁸F-FMISO PET.
Huang S, Michalek JE, Reardon DA, Wen PY, Floyd JR, Fox PT, Clarke GD, Jerabek PA, Schmainda KM, Muzi M, Hyun H, Lee EQ, Brenner AJ
Sci Rep, 11(1):7632, 07 Apr 2021
Cited by: 14 articles | PMID: 33828310 | PMCID: PMC8027395
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial.
Schmainda KM, Prah MA, Marques H, Kim E, Barboriak DP, Boxerman JL
Neuro Oncol, 23(2):314-323, 01 Feb 2021
Cited by: 15 articles | PMID: 32678438 | PMCID: PMC7906067
Add to export list Free full text in Europe PMC
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, [...] Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee
Neuro Oncol, 22(9):1262-1275, 01 Sep 2020
Cited by: 94 articles | PMID: 32516388 | PMCID: PMC7523451
Add to export list Review Free full text in Europe PMC
Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.
Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ
Int J Radiat Oncol Biol Phys, 108(4):979-986, 27 Jun 2020
Cited by: 12 articles | PMID: 32599030 | PMCID: PMC8655709
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Evaluating the Use of rCBV as a Tumor Grade and Treatment Response Classifier Across NCI Quantitative Imaging Network Sites: Part II of the DSC-MRI Digital Reference Object (DRO) Challenge.
Bell LC, Semmineh N, An H, Eldeniz C, Wahl R, Schmainda KM, Prah MA, Erickson BJ, Korfiatis P, Wu C, Sorace AG, Yankeelov TE, Rutledge N, Chenevert TL, Malyarenko D, Liu Y, Brenner A, Hu LS, Zhou Y, [...] Quarles CC
Tomography, 6(2):203-208, 01 Jun 2020
Cited by: 8 articles | PMID: 32548297 | PMCID: PMC7289259
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The cytotoxicity of gallium maltolate in glioblastoma cells is enhanced by metformin through combined action on mitochondrial complex 1.
Alhajala HS, Markley JL, Kim JH, Al-Gizawiy MM, Schmainda KM, Kuo JS, Chitambar CR
Oncotarget, 11(17):1531-1544, 28 Apr 2020
Cited by: 6 articles | PMID: 32391122 | PMCID: PMC7197450
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Human Fetal Tissue from Elective Abortions in Research and Medicine: Science, Ethics, and the Law.
Lee TS, Feeney MB, Schmainda KM, Sherley JL, Prentice DA
Issues Law Med, 35(1):3-61, 01 Jan 2020
Cited by: 1 article | PMID: 33950608
Add to export list

1-25 of 91 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Multi-Site Benchmark Study for Standardized Relative Cerebral Blood Volume in Untreated Brain Metastases Using the DSC-MRI Consensus Acquisition Protocol.

Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.

Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.

Practical guidance to identify and troubleshoot suboptimal DSC-MRI results.

Application of Delta T1 maps for quantitative and objective assessment of extent of resection and survival prediction in glioblastoma.

Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.

Magnetic resonance imaging-derived relative cerebral blood volume characteristics in a case of pathologically confirmed neurocysticercosis: illustrative case.

Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.

A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength.

Advanced MR Techniques for Preoperative Glioma Characterization: Part 2.

Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625.

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma.

Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions.

Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity.

High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques.

High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.

Magnetic Resonance Imaging Mapping of Brain Tumor Burden: Clinical Implications for Neurosurgical Management: Case Report.

Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness.

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and ¹⁸F-FMISO PET.

Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial.

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.

Evaluating the Use of rCBV as a Tumor Grade and Treatment Response Classifier Across NCI Quantitative Imaging Network Sites: Part II of the DSC-MRI Digital Reference Object (DRO) Challenge.

The cytotoxicity of gallium maltolate in glioblastoma cells is enhanced by metformin through combined action on mitochondrial complex 1.

Human Fetal Tissue from Elective Abortions in Research and Medicine: Science, Ethics, and the Law.

Partnerships & funding